Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
First-in-human, double-blind, randomized phase 1b study of peptide immunotherapy IMCY-0098 in new-onset type 1 diabetes.
Van Rampelbergh J, Achenbach P, Leslie RD, Ali MA, Dayan C, Keymeulen B, Owen KR, Kindermans M, Parmentier F, Carlier V, Ahangarani RR, Gebruers E, Bovy N, Vanderelst L, Van Mechelen M, Vandepapelière P, Boitard C. Van Rampelbergh J, et al. Among authors: van mechelen m. BMC Med. 2023 May 24;21(1):190. doi: 10.1186/s12916-023-02900-z. BMC Med. 2023. PMID: 37226224 Free PMC article. Clinical Trial.
Cellular and molecular diversity in spondyloarthritis.
Gulino GR, Van Mechelen M, Lories R. Gulino GR, et al. Among authors: van mechelen m. Semin Immunol. 2021 Dec;58:101521. doi: 10.1016/j.smim.2021.101521. Epub 2021 Nov 9. Semin Immunol. 2021. PMID: 34763975 Review.
Correction to: Behavior of metastatic breast cancer according to subtype.
Van Mechelen M, Van Herck A, Punie K, Nevelsteen I, Smeets A, Neven P, Weltens C, Han S, Vanderstichele A, Floris G, Lobelle JP, Wildiers H. Van Mechelen M, et al. Breast Cancer Res Treat. 2021 Apr;186(2):587-589. doi: 10.1007/s10549-020-06006-5. Breast Cancer Res Treat. 2021. PMID: 33410978 No abstract available.
Behavior of metastatic breast cancer according to subtype.
Van Mechelen M, Van Herck A, Punie K, Nevelsteen I, Smeets A, Neven P, Weltens C, Han S, Vanderstichele A, Floris G, Lobelle JP, Wildiers H. Van Mechelen M, et al. Breast Cancer Res Treat. 2020 May;181(1):115-125. doi: 10.1007/s10549-020-05597-3. Epub 2020 Mar 19. Breast Cancer Res Treat. 2020. PMID: 32193802
Bone Disease in Axial Spondyloarthritis.
Van Mechelen M, Gulino GR, de Vlam K, Lories R. Van Mechelen M, et al. Calcif Tissue Int. 2018 May;102(5):547-558. doi: 10.1007/s00223-017-0356-2. Epub 2017 Oct 31. Calcif Tissue Int. 2018. PMID: 29090349 Review.
Impact of adjuvants on CD4(+) T cell and B cell responses to a protein antigen vaccine: Results from a phase II, randomized, multicenter trial.
Leroux-Roels G, Marchant A, Levy J, Van Damme P, Schwarz TF, Horsmans Y, Jilg W, Kremsner PG, Haelterman E, Clément F, Gabor JJ, Esen M, Hens A, Carletti I, Fissette L, Tavares Da Silva F, Burny W, Janssens M, Moris P, Didierlaurent AM, Van Der Most R, Garçon N, Van Belle P, Van Mechelen M. Leroux-Roels G, et al. Among authors: van mechelen m. Clin Immunol. 2016 Aug;169:16-27. doi: 10.1016/j.clim.2016.05.007. Epub 2016 May 25. Clin Immunol. 2016. PMID: 27236001 Free article. Clinical Trial.
46 results